Monique M. Hedderson, PhD

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3580 (phone)
Monique.m.hedderson@kp.org
Kaiser Permanente Researcher Profiles

Monique Hedderson, PhD, is a research scientist at the Kaiser Permanente Northern California Division of Research. She received her Master's in public health from the University of Washington in 2000 and her PhD in epidemiology from the University of Washington in 2005. Dr. Hedderson’s research interests lie principally, but not exclusively, in the field of maternal and child health. Her research portfolio investigates the influence of preconception, prenatal and early childhood exposures on maternal and child health. Specifically, she has sought to understand how potentially modifiable factors before and during early pregnancy contribute to the risk of metabolic complications in women during pregnancy and postpartum, as well as their children. Dr. Hedderson has a long-standing interest in developing innovative targeted prevention and treatment strategies for high risk populations, especially interventions among reproductive aged women that can be implemented into clinical practice. She is also interested in the pharmacogenetics of glycemic response to metformin among patients with type 2 diabetes. This area of research has the potential to inform data-driven prescribing and precision medicine for antidiabetic drug therapy.

Current Position(s):

Research Scientist II, Division of Research, Kaiser Permanente Northern California

Section Affiliations:

Primary Research Interests:

Reproductive and perinatal epidemiology
Gestational diabetes
In utero behavioral and environmental exposures related to maternal and child health

Studies

Development and Testing of a Mobile-Health (m-health) Intervention tool to Help Obese Women Achieve Appropriate Gestational Weight Gain

To determine whether a mobile-health (m-health) tool (accessible via smartphone or website) intervention for obese pregnant improves patient satisfaction with their gestational weight gain, quality of life, stress and depression during pregnancy. Provider satisfaction with discussing gestational weight gain among their patients who used the m-health tool will also be assessed.
Investigator: Hedderson, Monique
Funder: The Permanente Medical Group

Glyburide Versus Insulin for the Treatment of Women with Gestational Diabetes in Kaiser Permanente Northern California

We aim to compare the effectiveness and safety of glyburide and insulin at improving neonatal and maternal outcomes among women with gestational diabetes mellitus (GDM) requiring medication therapy in Kaiser Permanente Northern California from 2007 to 2016. We will use a cohort study design including women with GDM diagnosed from 2007 to 2016 where treatment groups contrasted are defined by therapy regimens (i.e., insulin versus glyburide or early versus late initiation of glyburide). This project will overcome shortcomings of past studies conducted in this area by using modern statistical methods that allow us to take advantage of variation in treatment patterns after the implementation of the universal Perinatal Center referral policy in 2007. More specifically, our approach consists of a cohort study with time-varying exposure to insulin and glyburide during pregnancy.
Investigator: Hedderson, Monique
Funder:

Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States

This study will estimate the incidence of pulmonary hypothyroid in a pediatric population of children under age 4, based on data from the US-based Kaiser Permanente Northern California database, who were exposed to iodinated contrast agent through having a diagnostic procedure.
Investigator: Hedderson, Monique
Funder: Bayer AG

Pregravid Biomarkers and Risk of Gestational Diabetes Mellitus Risk, Fetal Growth and Progression to Diabetes

This study will examine pregravid biomarkers of metabolic risk (adiponectin, high molecular weight adiponectin, c-reactive protein, liver enzymes, fetuin-A and LDL particle size) in relation to risk of gestational diabetes mellitus among women who participated in the Kaiser Permanente Northern California (KPNC) multiphasic health check-up (1985-1996) and had a subsequent pregnancy in KPNC.
Investigator: Hedderson, Monique
Funder: National Institute of Child Health and Human Development

Discovery of Pharmacogenomic Biomarkers for Metformin Response

The primary goal of this multi-site study is to identify genetic variants that impact response to metformin in patients with diabetes from multiple ethnic groups in the U.S. and Europe
Investigator: Hedderson, Monique
Funder: National Institute of General Medical Sciences

Pharmacogenomics Study of Extreme Response to Metformin

In this collaboration with GlaxoSmithKline, University of California San Francisco and Kaiser Permanente Northern California, we propose to perform a genome-wide association study in 1,000 patients of European ancestry with extreme response phenotypes to metformin using genomewide array and human exome chip, which include rare nonsynonymous variants. Our aim is to determine whether rare variants, either acting alone or in combination, explain much of the variation in response to metformin, particularly in the extreme responder and non-responder groups.
Investigator: Hedderson, Monique
Funder: GlaxoSmithKline PLC

Highlighted Publications

No results found matching criteria

Publications

A cohort study of maternal cardiometabolic risk factors and primary cesarean delivery in an integrated health system

Author(s): Hedderson MM; Xu F; Sridhar SB; Han ES; Quesenberry CP; Crites Y

PLoS ONE. 2018;13(7):e0199932. Epub 2018-07-03.

Current Position(s):

Section Affiliations:

Primary Research Interests:

Studies

Development and Testing of a Mobile-Health (m-health) Intervention tool to Help Obese Women Achieve Appropriate Gestational Weight Gain

Glyburide Versus Insulin for the Treatment of Women with Gestational Diabetes in Kaiser Permanente Northern California

Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States

Pregravid Biomarkers and Risk of Gestational Diabetes Mellitus Risk, Fetal Growth and Progression to Diabetes

Discovery of Pharmacogenomic Biomarkers for Metformin Response

Pharmacogenomics Study of Extreme Response to Metformin

Highlighted Publications

Publications

A cohort study of maternal cardiometabolic risk factors and primary cesarean delivery in an integrated health system

A Tailored Letter Based on Electronic Health Record Data Improves Gestational Weight Gain Among Women With Gestational Diabetes: The Gestational Diabetes' Effects on Moms (GEM) Cluster-Randomized Controlled Trial

Genetic Variants in CPA6 and PRPF31 are Associated with Variation in Response to Metformin in Individuals with Type 2 Diabetes

The Pregnancy Environment and Lifestyle Study (PETALS); a population-based longitudinal multi-racial birth cohort

Perceived psychosocial stress and gestational weight gain among women with gestational diabetes

The Kaiser Permanente Northern California research program on genes, environment, and health (RPGEH) pregnancy cohort; study design, methodology and baseline characteristics.

Variants in Pharmacokinetic Transporters and Glycaemic Response to Metformin: A MetGen Meta-Analysis

Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin

Trimester-Specific Gestational Weight Gain and Infant Size for Gestational Age

A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on Metformin

Lifestyle behaviors and ethnic identity among diverse women at high risk for type 2 diabetes

​The Comparative Effectiveness of Diabetes Prevention Strategies to Reduce Postpartum Weight Retention in Women With Gestational Diabetes Mellitus; The Gestational Diabetes' Effects on Moms (GEM) Cluster Randomized Controlled Trial.

Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes

Outreach to diversify clinical trial participation: A randomized recruitment study

Response to Comment on Hedderson et al. Prepregnancy SHBG Concentrations and Risk for Subsequently Developing Gestational Diabetes Mellitus. Diabetes Care 2014;37:1296-1303

Genetic Variants in Transcription Factors Are Associated With the Pharmacokinetics and Pharmacodynamics of Metformin

Maternal gestational weight gain and offspring risk for childhood overweight or obesity

A Call to Increase Physical Activity Among Women of Reproductive Age: Is It Possible?

Pregravid Liver Enzyme Levels and Risk of Gestational Diabetes During a Subsequent Pregnancy

Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer

Post-partum weight loss and glucose metabolism in women with gestational diabetes: the DEBI Study

Prepregnancy SHBG Concentrations and Risk for Subsequently Developing Gestational Diabetes Mellitus

The Multigroup Ethnic Identity Measure-Revised: Measurement Invariance Across Racial and Ethnic Groups

Low Prepregnancy Adiponectin Concentrations Are Associated With a Marked Increase in Risk for Development of Gestational Diabetes Mellitus

Risk of Large-for-Gestational-Age Newborns in Women With Gestational Diabetes by Race and Ethnicity and Body Mass Index Categories

Pregnancy Glycemia in Mexican-American Women Without Diabetes or Gestational Diabetes and Programming for Childhood Obesity

Pregnancy Glucose Levels in Women without Diabetes or Gestational Diabetes and Childhood Cardiometabolic Risk at 7 Years of Age

Sex ratio variations among the offspring of women with diabetes in pregnancy

Racial/Ethnic Disparities in the Prevalence of Gestational Diabetes by BMI

Prepregnancy cardiometabolic and inflammatory risk factors and subsequent risk of hypertensive disorders of pregnancy

Referral to telephonic nurse management improves outcomes in women with gestational diabetes

A pregnancy and postpartum lifestyle intervention in women with gestational diabetes mellitus reduces diabetes risk factors: a feasibility randomized control trial

Pregravid cardiometabolic risk profile and risk for gestational diabetes mellitus

Change in body mass index between pregnancies and the risk of gestational diabetes in a second pregnancy

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study

The risk of large for gestational age across increasing categories of pregnancy glycemia

Disparities in the risk of gestational diabetes by race-ethnicity and country of birth

Gestational weight gain and risk of gestational diabetes mellitus

Contraception before and after GDM

High blood pressure before and during early pregnancy is associated with an increased risk of gestational diabetes mellitus

Body mass index and weight gain prior to pregnancy and risk of gestational diabetes mellitus

Androgenicity of progestins in hormonal contraceptives and the risk of gestational diabetes mellitus

Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia

Pregnancy weight gain and risk of neonatal complications: macrosomia, hypoglycemia, and hyperbilirubinemia

An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000

Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth

Allergy and risk of breast cancer among young women (United States)

Changes in diet, physical activity, and supplement use among adults diagnosed with cancer

Prevalence of gestational diabetes mellitus detected by the national diabetes data group or the carpenter and coustan plasma glucose thresholds

The Comparative Effectiveness of Diabetes Prevention Strategies to Reduce Postpartum Weight Retention in Women With Gestational Diabetes Mellitus; The Gestational Diabetes' Effects on Moms (GEM) Cluster Randomized Controlled Trial.